Essentials of Global Health is a comprehensive introduction to global health. It is meant to introduce you to this topic in well-structured, clear and easy to understand ways. Much of the course will focus on five questions: What do people get sick, disabled and die from; Why do they suffer from these conditions? Which people are most affected? Why should we care about such concerns? What can be done to address key health issues, hopefully at least cost, as fast as possible, and in sustainable ways? The course will be global in coverage but with a focus on low- and middle-income countries, the health of the poor, and health disparities. Particular attention will be paid throughout the course to health systems issues, the linkages between health and development, and health matters related to global interdependence. The course will cover key concepts and frameworks but be practical in orientation. ------------------------------------------------------------------------------------------------------------------------------------------------------- Course Learning Objectives By the end of the course, learners should be able to: • Articulate key public health concepts related to global health; • Analyze the key issues in global health from a number of perspectives; • Discuss with confidence the burden of disease in various regions of the world; how it varies by sex, age, and location; key risk factors for this burden; and how the disease burden can be addressed in cost-effective ways; • Assess key health disparities, especially as they relate to the health of low-income and marginalized people in low- and middle-income countries; • Outline the key actors and organizations in global health and the manner in which they cooperate to address critical global health concerns; • Review key global health challenges that are likely to arise in the coming decades. ------------------------------------------------------------------------------------------------------------------------------------------------------- Value Added of the Course The course seeks to add special value by being comprehensive, by handling each topic in a consistent framework, and by helping learners gain an understanding of well grounded approaches to assessing global health issues and what can be done to address them. ------------------------------------------------------------------------------------------------------------------------------------------------------- The Readings and other materials for Essentials of Global Health For almost every session of Essentials of Global Health, you will see: - Required readings - Recommended readings - Recommended videos We have selected a small number of readings for each session that are central to understanding the content of the session. We have put these under “required readings”. For each required reading, we have also indicated how carefully you should read the material and on what parts of the material you should focus your attention. In addition, we have selected some additional readings that would be very helpful to your understanding the content of each session. The first is a textbook, Global Health 101, third edition. This is a comprehensive introductory textbook that closely follows the content of this Essentials of Global Health course. We have indicated for each session what part of the book you should read. Using this textbook can be very valuable to your mastering the content of the course. The second set of “recommended readings” is some additional readings, mostly from journal articles and reports. For these, too, we have indicated how carefully you should read the material and on what parts of the material you should focus your attention. Learners should note that to access articles from The Lancet they will have to register with the Lancet, if they do not have online access to a library that has The Lancet. Once they are registered, they will be able to sign into The Lancet and access all of its free articles. We have also indicated for most sessions one or two videos that relate to the topic of the session. These are meant to help the learner get a better feel for the topic which is being covered. Most learners will find the videos brief, easy and enjoyable to watch, and very enlightening.
Value for Money in Global Health
Loading...
Del curso dictado por Yale University
Essentials of Global Health
195 calificaciones
De la lección
Module 3: Health Systems and Value for Money in Health
Module 3 focuses on health systems. It first examines the notion of “value for money” in considering investments in health. It then reviews how health systems in different parts of the world are organized; some of the issues they face in effectively and efficiently providing appropriate services of acceptable quality; and what we are learning can be done to address those issues in cost-effective ways.
Conoce a los instructores
Richard SkolnikFormer Lecturer, Department of Health Policy and Management, Yale School of Public Health and Lecturer in the Practice of Management, Yale School of Management, 2012-2016
Welcome.
In this session, we'll talk about value for
money when investing in key global health efforts.
By the time you fish this session,
you should be able to speak about the notion of value for money and health.
Articulate some of the basic principles of cost effectiveness analysis and
note some of the best buys in global health.
Let's start with some stories and then probe our students about them.
Rachel, and this is are slightly, if not very exaggerated,
but I hope you'll find them useful to make some important points.
Rachel, you have a chance to buy a tablet device, let's say,
and you have a chance to buy either for $299 or for $399.
You can buy it from two different firms, both are highly regarded.
Both can deliver the same exact tablet to you.
At exactly the same time right to your door.
If you could do this for $299 or $399,
which would you choose and why would you choose it?
>> I would choose to buy the tablet for $299.
>> And why is that?
>> Because if they're the same tablet, then it makes the most sense for
me to spend as little money as possible.
>> To get exactly the same outcome, if you would.
Elizabeth, now let's look at an example from clinical medicine,
again, highly exaggerated.
John has heartburn, he can take a simple antacid or
he can take an over the counter acid inhibitor.
Let's say that in both cases, John has exactly the same clinical outcome.
If it takes antacid the course of treatment is going to be, let's say,
1 US dollar.
If he takes the acid inhibitor, let's say the course of treatment get to the exactly
the same outcome or repeat that he could get antacid is going to 6 US dollar.
In this case, Elizabeth, if you were John and paying out of your own pocket,
for example, which would you take the antacid for $1 or
the acid inhibitor for $6, to achieve the same clinical outcome?
>> I would choose the antacid for $1.
>> And why is that?
>> Because it doesn't make a lot sense when you could use those $5 to purchase
other things.
It makes more sense,
if you're going to reach the same outcome to spend as little as possible.
>> Okay, very well said.
So if you have unlimited money, or I have unlimited money, or
governments have unlimited money, these questions might not be so relevant.
But I want to suggest that money is never unlimited and
that choices always have to be made between investment alternatives.
So let's talk a little bit about one approach to
considering alternative investments.
And in which countries might want to spend their money.
All governments have to set priorities, and one tool that they might use
to set those priorities is called cost effectiveness analysis.
This can be defined in simple terms as a method for
comparing the cost of an investment
with the amount of health that can be purchased with that investment.
The cost is the price of the investment.
The amount of health that can be purchased could be measured for example,
in deaths averted, DALYs averted, or narrower goals.
Such as the cost per child fully immunized, or
the cost per TB patient was cured.
The cost effectiveness of an intervention
relates in part to the incidents, the number of new cases and the prevalence,
the number of people with a certain condition.
This cost effect and
will also depend on the cost of intervention, the outcome's produced and
the extent to which the intervention can be implemented affectively.
So let's examine, a very simplified and exaggerated example
of a question that one might want to use cost effectiveness analysis to consider.
In this case, let's think about tuberculosis control.
Quite some time ago in fact one of the classic examples of cost effectiveness
analysis, use this technique,
this approach to look at two different ways of providing tuberculosis care.
In one case, tuberculosis is done in an unobserved manner.
If for example, Shaylan, God forbid had tuberculosis,
we would give her her TB drugs.
We would talk to her about taking all those drugs, and
then she would hopefully take the drugs.
In another case, we would carry out what we call, directly observed therapy.
In that case, let's say that Elizabeth is a respected person in the community.
She's a minister, she's a school teacher, she's a wise, older women.
What we would do is give Elizabeth the drugs and
each day Shaylene would go to Elizabeth for those drugs.
Pick them up, take the drug in front of Elizabeth, and Elizabeth would
certify to the supervisors that Shaylene had taken her drugs properly.
So let's see which of these cases turns out to be
the one that's most cost effective.
So let's say, for example, in the case of the unobserved therapy,
the first one that I mentioned.
Let's say that the cost per patient is $180.
Let's say that 70% of the patients who take this therapy are cured.
And remember, when we're talking about tuberculosis and many other interventions,
we're not really interested in how many people take their drugs.
What we're really interested in is the outcome.
How many people successfully complete treatment and are cured?
Now, we also a second approach, which is directly observed therapy.
In this case, it's $200 per patient,
it's more expensive, but 90% of the patients are cured.
Which is a higher cure rate than you have in the case of unobserved therapy.
So let's work this out and see what's the cost per patient cured?
Again, I remind you this is a highly simplified case, but
I hope it's one that's useful for
helping you to understand some of the principles involved.
So let's say that we treat ten people for tuberculosis in village x.
Again, the cost was $180 per patient, and 7 of the patients were cured.
We would have spent $1,800 to cure 7 patients when
we divide 1,800 by 7 what we get is $257 per patient cured.
In the other case of observed therapy, it was $200 per patient to treat,
treating 10 of them would be $2,000.
But 9 of the 10 would be cured and therefore,
when we divide 9 into 2,000, we get $222 per patient cured.
So in this case,
even though observed therapy is more expensive than unobserved therapy.
It turns out that observed therapy is also more cost effective.
The cost per patient cured with observed therapy is less than
the cost per patient cured with unobserved therapy.
If you were a policy maker, you'd also take account of other concerns,
that would it be doable, would it be sustainable, would it be affordable?
But if those things were at least equal, what you would do is, you would certainly
choose the case of the observed therapy, because it's more cost effective.
Now we can also use cost effectiveness analysis
to compare across different kinds of investments.
Let's again talk in extremely simple terms for which I apologize only a bit,
and for which I beg your indulgence is I guess what I should probably say.
So let's say there's a government that has just
$10,000 equivalent to spend on health.
And let's say that this government has just two choices of
investment alternatives.
One choice and this of course, would never be the case,
the world is never this simple.
But one choice is the government could use its public funds
from the ministry's health budget to finance heart surgery for one person.
And let's say that one person as a result of this surgery
will live 20 years longer than he would if he didn't get the surgery.
The only other investment choice in the country
is to vaccinate 1,000 children against vaccine preventable diseases.
And when they do that,
there are 10 children who would still come around 5 years of age.
If they didn't vaccinate, they save 65 years of life, let's say,
if they would have live to 70.
They live 65 years of additional life for each child vaccinated.
And therefore, they save through this program 650 life years.
Now in this case, if the government had to choose between these two investments.
And it only had these two investments from which it could choose,
the choice would be rather clear.
In this case, they would opt for vaccinating a 1,000 children,
because with the same amount of money.
They could buy much more health for their people than they could buy,
if they used that money to provide heart surgery to just a single patient.
In fact, let's now look at a slide that shows data on the cost
effectiveness of a number of interventions.
In this case, the amount of money spent is compared with
the number of DALYs that can be averted through that intervention.
And you see here a substantial range of dollars per DALY averted.
As we had in the exaggerated example, we can see that the dollars per DALY averted.
For example, coronary bypass surgery is much,
much greater than the cost for dollars per DALY averted for
oral rehydration therapy for young children for diarrhea.
And improved emergency obstetric care, TB treatment or for
example, basic childhood vaccines.
You should understand, there's no absolute guideline for
what's cost effective and what's not.
Over the last several decades, the World Health Organization had been recommending
that an investment could be considered cost effective.
If it was less than three times the gross national product per capita of a country.
But you should be aware that many people had important critiques of that approach.
But at least when you use this kind of analysis, you can see what at
least is the relative cost per outcome of different kinds of investments.
And certainly your choices of investments,
can be enlightened by using this kind of analysis.
Now you should understand that cost effectiveness analysis
is only one of many tools for making investment choices in health.
In addition, in the real world which isn't nearly as exaggerated as this.
And which is much more complicated,
one has to take account of a number of factors.
Such as politics, the role and place of different political
actors in thinking about investment choices.
In addition, as you think about cost effectiveness analysis and
as you use it for helping you to make investment decisions in health.
It's really essential to consider equity, the burden of disease,
the extent to which the investment serves society as a whole.
The extent to which the investment produces benefits additional to its usual
ones, and the impact of the intervention on the provision of insurance.
In addition, those who set priorities for investing in health
will have to take account of the capacity to deliver the purpose services,
they're not cost effective if they can't be implemented.
The links between the services in which you might be investing and
existing services.
The ability to change budget priorities in favor of the proposed investment.
And any transitional costs that are associated with making those moves,
to a new set, for example, of priorities.
Now let me end by saying, or come close ending by saying,
it's true in my view that many low resource
countries need to invest more in health.
But I also want to suggest to you that even in those countries,
how they spend money is at least as important,
if not more important than how much they spend.
In this session,
you've learned a bit about the notion of cost effectiveness analysis.
You applied the tool cost effectiveness analysis to a number of very
exaggerated and simplified cases.
You become more familiar with the idea of value for money and health.
And you understand more about some of the important considerations that
you have to keep in mind as you use the cost effectiveness analysis tool.
In the next session,
we'll begin to speak about health systems in different countries.
Explora nuestro catálogo
Inscríbete de manera gratuita y obtén recomendaciones personalizadas, actualizaciones y ofertas.
Coursera brinda acceso universal a la mejor educación del mundo, al asociarse con las mejores universidades y organizaciones, para ofrecer cursos en línea.
© 2019 Coursera Inc. Todos los derechos reservados.
